BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ménégoz F, Black RJ, Arveux P, Magne V, Ferlay J, Buémi A, Carli PM, Chapelain G, Faivre J, Gignoux M. Cancer incidence and mortality in France in 1975-95. Eur J Cancer Prev. 1997;6:442-466. [PMID: 9466116 DOI: 10.1097/00008469-199710000-00005] [Cited by in Crossref: 77] [Cited by in F6Publishing: 64] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Venara A, Barbieux J, Colas PA, Le Fouler A, Lermite E, Hamy A. Primary Surgery for Malignant Large Bowel Obstruction: Postoperative Nasogastric Tube Reinsertion is Not Mandatory. World J Surg. 2017;41:1903-1909. [PMID: 28265731 DOI: 10.1007/s00268-017-3949-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
2 Cézé N, Charachon A, Locher C, Aparicio T, Mitry E, Barbieux JP, Landi B, Dorval E, Moussata D, Lecomte T. Safety and efficacy of palliative systemic chemotherapy combined with colorectal self-expandable metallic stents in advanced colorectal cancer: A multicenter study. Clin Res Hepatol Gastroenterol. 2016;40:230-238. [PMID: 26500200 DOI: 10.1016/j.clinre.2015.09.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
3 Castel P, Tassy L, Lurkin A, Blay J, Meeus P, Mignotte H, Faure C, Ranchere-vince D, Bachelot T, Guastalla J, Sunyach M, Guerin N, Treilleux I, Marec-berard P, Thiesse P, Ray-coquard I. Multidisciplinarity and medical decision, impact for patients with cancer: sociological assessment of two tumour committees’ organization. Bulletin du Cancer 2012;99:E34-42. [DOI: 10.1684/bdc.2012.1559] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
4 Ducimetière F, Lurkin A, Ranchère-Vince D, Decouvelaere AV, Péoc'h M, Istier L, Chalabreysse P, Muller C, Alberti L, Bringuier PP, Scoazec JY, Schott AM, Bergeron C, Cellier D, Blay JY, Ray-Coquard I. Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing. PLoS One 2011;6:e20294. [PMID: 21826194 DOI: 10.1371/journal.pone.0020294] [Cited by in Crossref: 290] [Cited by in F6Publishing: 264] [Article Influence: 26.4] [Reference Citation Analysis]
5 Lurkin A, Ducimetière F, Vince DR, Decouvelaere AV, Cellier D, Gilly FN, Salameire D, Biron P, de Laroche G, Blay JY, Ray-Coquard I. Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region. BMC Cancer 2010;10:150. [PMID: 20403160 DOI: 10.1186/1471-2407-10-150] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 4.6] [Reference Citation Analysis]
6 Mastrangelo G, Fadda E, Cegolon L, Montesco MC, Ray-Coquard I, Buja A, Fedeli U, Frasson A, Spolaore P, Rossi CR. A European project on incidence, treatment, and outcome of sarcoma. BMC Public Health 2010;10:188. [PMID: 20384990 DOI: 10.1186/1471-2458-10-188] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
7 Rubino C, Arriagada R, Delaloge S, Lê MG. Relation of risk of contralateral breast cancer to the interval since the first primary tumour. Br J Cancer 2010;102:213-9. [PMID: 19920826 DOI: 10.1038/sj.bjc.6605434] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
8 Tran Vuong TN, Le Prisé E, Vauléon E, Boucher E, Audrain O, Raoul J. Chemoradiotherapy for cancer of the esophagus: contribution of the leucovorin, 5-fluorouracil bolus, and infusion-cisplatin-radiotherapy schedule starting with two neoadjuvant chemotherapy cycles: results from a pilot study: Chemoradiotherapy for cancer of the esophagus. Diseases of the Esophagus 2010;23:324-8. [DOI: 10.1111/j.1442-2050.2009.01016.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
9 Nguyen F, Rubino C, Guerin S, Diallo I, Samand A, Hawkins M, Oberlin O, Lefkopoulos D, De Vathaire F. Risk of a Second Malignant Neoplasm After Cancer in Childhood Treated With Radiotherapy: Correlation With the Integral Dose Restricted to the Irradiated Fields. International Journal of Radiation Oncology*Biology*Physics 2008;70:908-15. [DOI: 10.1016/j.ijrobp.2007.10.034] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
10 Colonna M, Danzon A, Delafosse P, Mitton N, Bara S, Bouvier AM, Ganry O, Guizard AV, Launoy G, Molinie F, Sauleau EA, Schvartz C, Velten M, Grosclaude P, Tretarre B. Cancer prevalence in France: time trend, situation in 2002 and extrapolation to 2012. Eur J Cancer 2008;44:115-22. [PMID: 18032021 DOI: 10.1016/j.ejca.2007.10.022] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
11 Heymann S, Jung GM, Simon P, Bergerat JP, Borel C, Di Marco A, Kurtz JE, Marcellin L, Ghnassia JP, Dufour P, Noël G. [Late outcome of 89 patients with soft-tissue sarcomas treated by surgery and three different radiotherapy schedules]. Cancer Radiother 2007;11:443-51. [PMID: 17981486 DOI: 10.1016/j.canrad.2007.09.143] [Reference Citation Analysis]
12 Di Fiore F, Lecleire S, Pop D, Rigal O, Hamidou H, Paillot B, Ducrotté P, Lerebours E, Michel P. Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. Am J Gastroenterol 2007;102:2557-63. [PMID: 17680847 DOI: 10.1111/j.1572-0241.2007.01437.x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 112] [Article Influence: 7.7] [Reference Citation Analysis]
13 Khedis M, Bellec L, Leobon B, Thoulouzan M, Labarthe P, Nohra J, Soulie M, Huyghe E, Plante P. [Partial nephrectomy by selective renal parenchymal clamping using a new clamp]. Prog Urol 2007;17:41-4. [PMID: 17373235 DOI: 10.1016/s1166-7087(07)92223-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
14 Billette de Villemeur A, Exbrayat C, Garnier A, Ancelle-park R, Ferley J, Jestin C. Evaluation of a combined screening programme for breast, cervical and colorectal cancers in France. European Journal of Cancer Prevention 2007;16:26-35. [DOI: 10.1097/01.cej.0000228399.30235.bc] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
15 Fiore FD, Lecleire S, Rigal O, Galais MP, Soussan EB, David I, Paillot B, Jacob JH, Michel P. Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma. World J Gastroenterol 2006; 12(26): 4185-4190 [PMID: 16830371 DOI: 10.3748/wjg.v12.i26.4185] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 50] [Article Influence: 3.0] [Reference Citation Analysis]
16 Di Fiore F, Lecleire S, Galais M, Rigal O, Vié B, David I, Hamidou H, Paillot B, Jacob J, Michel P. Impact of radiation schedule and chemotherapy duration in definitive chemoradiotherapy regimen for esophageal cancer. Gastroentérologie Clinique et Biologique 2006;30:845-51. [DOI: 10.1016/s0399-8320(06)73331-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
17 Molinié F, Velten M, Remontet L, Bercelli P. Évolution de l’incidence du cancer broncho-pulmonaire en France (1978-2000). Revue des Maladies Respiratoires 2006;23:127-34. [DOI: 10.1016/s0761-8425(06)71475-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 1] [Article Influence: 1.4] [Reference Citation Analysis]
18 Blanchon F, Grivaux M, Zureik M, Marsal L, Asselain B, Lebas F, Orlando J, Steenhouwer F, Benichou-flurin M, Coëtmeur D, Collon T, David P, Delclaux B, Piquet J. CohorteKbp-2000-Cphg : évaluation des facteurs pronostiques de la survie du cancer bronchique primitif à 2 et 5 ans. Revue des Maladies Respiratoires 2006;23:165-71. [DOI: 10.1016/s0761-8425(06)71482-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
19 Quoix E, Mennecier B. Le cancer bronchique chez la femme. Revue des Maladies Respiratoires 2005;22:55-62. [DOI: 10.1016/s0761-8425(05)85773-0] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
20 Cutuli B, Cottu PH, Guastalla JP, Mechin H, Costa A, Jourdan R. A French national survey on infiltrating breast cancer: analysis of clinico-pathological features and treatment modalities in 1159 patients. Breast Cancer Res Treat 2006;95:55-64. [PMID: 16261401 DOI: 10.1007/s10549-005-9034-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
21 Catelinois O, Laurier D, Verger P, Rogel A, Colonna M, Ignasiak M, Hémon D, Tirmarche M. Uncertainty and Sensitivity Analysis in Assessment of the Thyroid Cancer Risk Related to Chernobyl Fallout in Eastern France. Risk Analysis 2005;25:243-52. [DOI: 10.1111/j.1539-6924.2005.00586.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
22 Alzahouri K, Lejeune C, Woronoff-lemsi M, Arveux P, Guillemin F. Cost-effectiveness analysis of strategies introducing FDG-PET into the mediastinal staging of non-small-cell lung cancer from the French healthcare system perspective. Clinical Radiology 2005;60:479-92. [DOI: 10.1016/j.crad.2004.10.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
23 Harmand P, Duval R, Delage C, Simon A. Ursolic acid induces apoptosis through mitochondrial intrinsic pathway and caspase-3 activation in M4Beu melanoma cells. Int J Cancer 2005;114:1-11. [DOI: 10.1002/ijc.20588] [Cited by in Crossref: 112] [Cited by in F6Publishing: 103] [Article Influence: 6.6] [Reference Citation Analysis]
24 Couris CM, Forêt-Dodelin C, Rabilloud M, Colin C, Bobin JY, Dargent D, Raudrant D, Schott AM. [Sensitivity and specificity of two methods used to identify incident breast cancer in specialized units using claims databases]. Rev Epidemiol Sante Publique 2004;52:151-60. [PMID: 15138394 DOI: 10.1016/s0398-7620(04)99036-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
25 Catelinois O, Verger P, Colonna M, Rogel A, Hemon D, Tirmarche M. PROJECTING THE TIME TREND OF THYROID CANCERS: ITS IMPACT ON ASSESSMENT OF RADIATION-INDUCED CANCER RISKS: . Health Physics 2004;87:606-14. [DOI: 10.1097/01.hp.0000138587.93203.c5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Minelli L, Stracci F, Prandini S, Moffa IF, La Rosa F. Gynaecological cancers in Umbria (Italy): trends of incidence, mortality and survival, 1978-1998. Eur J Obstet Gynecol Reprod Biol 2004;115:59-65. [PMID: 15223167 DOI: 10.1016/j.ejogrb.2003.11.026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
27 Grivaux M, Breton JL, Bombaron P, Kuntz P, Lebas FX, Mehdaoui A, Herman D, David P, Berruchon J, Delclaux B, Zureik M, Blanchon F. Lung cancer among women in France. Lung Cancer 2004;45:279-87. [DOI: 10.1016/j.lungcan.2004.02.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
28 Crocetti E, Capocaccia R, Casella C, Guzzinati S, Ferretti S, Rosso S, Sacchettini C, Spitale A, Stracci F, Tumino R. Population-based incidence and mortality cancer trends (1986–1997) from the network of Italian cancer registries. European Journal of Cancer Prevention 2004;13:287-95. [DOI: 10.1097/01.cej.0000136719.42948.5a] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
29 Ray-Coquard I, Thiesse P, Ranchère-Vince D, Chauvin F, Bobin JY, Sunyach MP, Carret JP, Mongodin B, Marec-Bérard P, Philip T, Blay JY. Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas. Ann Oncol 2004;15:307-15. [PMID: 14760127 DOI: 10.1093/annonc/mdh058] [Cited by in Crossref: 139] [Cited by in F6Publishing: 111] [Article Influence: 7.7] [Reference Citation Analysis]
30 Menu-Branthomme A, Rubino C, Shamsaldin A, Hawkins MM, Grimaud E, Dondon MG, Hardiman C, Vassal G, Campbell S, Panis X, Daly-Schveitzer N, Lagrange JL, Zucker JM, Chavaudra J, Hartman O, de Vathaire F. Radiation dose, chemotherapy and risk of soft tissue sarcoma after solid tumours during childhood. Int J Cancer 2004;110:87-93. [PMID: 15054872 DOI: 10.1002/ijc.20002] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 3.2] [Reference Citation Analysis]
31 Mennecier B, Lebitasy M, Moreau L, Hedelin G, Purohit A, Galichet C, Quoix E. Women and small cell lung cancer: social characteristics, medical history, management and survival. Lung Cancer 2003;42:141-52. [DOI: 10.1016/s0169-5002(03)00284-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Fizazi K, Rolland F, Chevreau C, Droz JP, Mery-Mignard D, Culine S, Escudier B. A phase II study of irinotecan in patients with advanced renal cell carcinoma. Cancer 2003;98:61-5. [PMID: 12833456 DOI: 10.1002/cncr.11474] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
33 Verger P, Catelinois O, Tirmarche M, Chérié-challine L, Pirard P, Colonna M, Hubert P. THYROID CANCERS IN FRANCE AND THE CHERNOBYL ACCIDENT: RISK ASSESSMENT AND RECOMMENDATIONS FOR IMPROVING EPIDEMIOLOGICAL KNOWLEDGE: . Health Physics 2003;85:323-9. [DOI: 10.1097/00004032-200309000-00008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
34 Roulland S, Lebailly P, Roussel G, Briand M, Cappellen D, Pottier D, Hardouin A, Troussard X, Bastard C, Henry-Amar M, Gauduchon P. BCL-2/JH translocation in peripheral blood lymphocytes of unexposed individuals: lack of seasonal variations in frequency and molecular features. Int J Cancer 2003;104:695-8. [PMID: 12640675 DOI: 10.1002/ijc.10975] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
35 de La Provôté S, Desoubeaux N, Paris C, Letourneux M, Raffaelli C, Galateau-Salle F, Gignoux M, Launoy G. Incidence of digestive cancers and occupational exposure to asbestos. Eur J Cancer Prev 2002;11:523-8. [PMID: 12457103 DOI: 10.1097/00008469-200212000-00003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
36 Lejeune C, Arveux P, Dancourt V, Fagnani F, Bonithon-kopp C, Faivre J. A simulation model for evaluating the medical and economic outcomes of screening strategies for colorectal cancer: . European Journal of Cancer Prevention 2003;12:77-84. [DOI: 10.1097/00008469-200302000-00012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
37 Ganry O. Phytoestrogen and breast cancer prevention: . European Journal of Cancer Prevention 2002;11:519-22. [DOI: 10.1097/00008469-200212000-00002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
38 Ducreux M, Rougier P, Pignon JP, Douillard JY, Seitz JF, Bugat R, Bosset JF, Merouche Y, Raoul JL, Ychou M, Adenis A, Berthault-Cvitkovic F, Luboinski M; Groupe Digestif of the Fédération Nationale des Centres de Lutte Contre le Cancer Digestif. A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma. Ann Oncol 2002;13:1185-91. [PMID: 12181240 DOI: 10.1093/annonc/mdf197] [Cited by in Crossref: 96] [Cited by in F6Publishing: 77] [Article Influence: 4.8] [Reference Citation Analysis]
39 Michel P, Magois K, Robert V, Chiron A, Lepessot F, Bodenant C, Roque I, Seng SK, Frebourg T, Paillot B. Prognostic value of TP53 transcriptional activity on p21 and bax in patients with esophageal squamous cell carcinomas treated by definitive chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2002;54:379-385. [PMID: 12243811 DOI: 10.1016/s0360-3016(02)02911-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol 2002;147:41-7. [PMID: 12100183 DOI: 10.1046/j.1365-2133.2002.04804.x] [Cited by in Crossref: 243] [Cited by in F6Publishing: 193] [Article Influence: 12.2] [Reference Citation Analysis]
41 Navas-Acién A, Pollán M, Gustavsson P, Plato N. Occupation, exposure to chemicals and risk of gliomas and meningiomas in Sweden. Am J Ind Med 2002;42:214-27. [PMID: 12210690 DOI: 10.1002/ajim.10107] [Cited by in Crossref: 80] [Cited by in F6Publishing: 65] [Article Influence: 4.0] [Reference Citation Analysis]
42 Crocetti E, Paci E, Miccinesi G, Costantini AS, Zappa M. Time trends in cancer incidence and mortality in central Italy: . European Journal of Cancer Prevention 2002;11:387-95. [DOI: 10.1097/00008469-200208000-00011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
43 Faivre-Finn C, Bouvier-Benhamiche AM, Phelip JM, Manfredi S, Dancourt V, Faivre J. Colon cancer in France: evidence for improvement in management and survival. Gut 2002;51:60-4. [PMID: 12077093 DOI: 10.1136/gut.51.1.60] [Cited by in Crossref: 97] [Cited by in F6Publishing: 88] [Article Influence: 4.9] [Reference Citation Analysis]
44 Baulieu F, Bourlier P, Scotto B, Mor C, Eder V, Picon L, De Calan L, Dorval E, Pottier JM, Baulieu JL. The value of immunoscintigraphy in the detection of recurrent colorectal cancer. Nucl Med Commun. 2001;22:1295-1304. [PMID: 11711899 DOI: 10.1097/00006231-200112000-00004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
45 Meindl A; German Consortium for Hereditary Breast and Ovarian Cancer. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Int J Cancer 2002;97:472-80. [PMID: 11802209 DOI: 10.1002/ijc.1626] [Cited by in Crossref: 158] [Cited by in F6Publishing: 146] [Article Influence: 7.9] [Reference Citation Analysis]
46 Chirpaz E, Colonna M, Menegoz F, Grosclaude P, Schaffer P, Arveux P, Lesec'h JM, Exbrayat C, Schaerer R. Incidence and mortality trends for prostate cancer in 5 French areas from 1982 to 1996. Int J Cancer 2002;97:372-6. [DOI: 10.1002/ijc.1603] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
47 Grosclaude P, Colonna M, Hedelin G, Tretarre B, Arveux P, Mace Lesec'h J, Raverdy N, Sauvage-machelard M. Survival of women with breast cancer in France: variation with age, stage and treatment. Breast Cancer Res Treat 2001;70:137-43. [DOI: 10.1023/a:1012974728007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
48 Benamouzig R, Yoon H, Little J, Martin A, Couturier D, Deyra J, Coste T, Chaussade S; APACC Study Group. Association pour la Prevention par Aspirine du Cancer Colorectal. APACC, a French prospective study on aspirin efficacy in reducing colorectal adenoma recurrence: design and baseline findings. Eur J Cancer Prev 2001;10:327-35. [PMID: 11535875 DOI: 10.1097/00008469-200108000-00006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
49 Levesque J, Bell RS, Coyte PC, Wright JG. Changing rates of cancer. Journal of Clinical Epidemiology 2001;54:225-31. [DOI: 10.1016/s0895-4356(00)00306-1] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
50 Glehen O, Traverse-Glehen A, Peyrat P, François Y, Gérard JP, Vignal J, Gilly FN. [Stomach adenocarcinoma. Evolution of surgical treatment in a series of 350 cases]. Ann Chir. 2000;125:744-751. [PMID: 11105346 DOI: 10.1016/s0003-3944(00)00268-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
51 Rubino C, de Vathaire F, Diallo I, Shamsaldin A, Lê MG. Increased risk of second cancers following breast cancer: role of the initial treatment. Breast Cancer Res Treat 2000;61:183-95. [PMID: 10965995 DOI: 10.1023/a:1006489918700] [Cited by in Crossref: 77] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
52 Alvarez-riesgo JA. Trends in breast cancer mortality in Asturias, Spain: . European Journal of Cancer Prevention 2000;9:343-50. [DOI: 10.1097/00008469-200010000-00009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
53 Benhamiche-bouvier AM, Clinurd F, Phelip JM, Rassiat E, Faivre J. Colorectal cancer prevalence in France: . European Journal of Cancer Prevention 2000;9:303-8. [DOI: 10.1097/00008469-200010000-00003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
54 Dhôte R, Pellicer-Coeuret M, Thiounn N, Debré B, Vidal-Trecan G. Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention. BJU Int 2000;86:20-7. [PMID: 10886077 DOI: 10.1046/j.1464-410x.2000.00708.x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 3.6] [Reference Citation Analysis]
55 Bey P, Carrie C, Beckendorf V, Ginestet C, Aletti P, Madelis G, Luporsi E, Pommier P, Cowen D, Gonzague-casabianca L, Simonian-sauve M, Maingon P, Naudy S, Lagrange J, Marcie S. Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer—preliminary results. International Journal of Radiation Oncology*Biology*Physics 2000;48:513-7. [DOI: 10.1016/s0360-3016(00)00691-x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
56 Pandey M, Shukla VK. Fatty acids, biliary bile acids, lipid peroxidation products and gallbladder carcinogenesis: . European Journal of Cancer Prevention 2000;9:165-72. [DOI: 10.1097/00008469-200006000-00003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
57 Schmezer P, Rupprecht T, Tisch M, Maier H, Bartsch H. Laryngeal mucosa of head and neck cancer patients shows increased DNA damage as detected by single cell microgel electrophoresis. Toxicology 2000;144:149-54. [DOI: 10.1016/s0300-483x(99)00201-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
58 André T, Bensmaine MA, Louvet C, François E, Lucas V, Desseigne F, Beerblock K, Bouché O, Carola E, Merrouche Y, Morvan F, Dupont-André G, de Gramont A. Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen. J Clin Oncol 1999;17:3560-8. [PMID: 10550155 DOI: 10.1200/JCO.1999.17.11.3560] [Cited by in Crossref: 212] [Cited by in F6Publishing: 34] [Article Influence: 9.6] [Reference Citation Analysis]
59 Colonna M, Hedelin G, Esteve J, Grosclaude P, Launoy G, Buemi A, Arveux P, Tretarre B, Chaplain G, Lesec'h JM, Raverdy N, Marie Carli P, Menegoz F, Faivre J. National cancer prevalence estimation in France. Int J Cancer 2000;87:301-4. [DOI: 10.1002/1097-0215(20000715)87:2<301::aid-ijc24>3.0.co;2-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
60 Conroy T, Kaminsky M, Peiffert D, Wolff P. Traitements non chirurgicaux des cancers de l'œsophage. La Revue de Médecine Interne 2000;21:58-73. [DOI: 10.1016/s0248-8663(00)87229-x] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
61 Colonna M, Grosclaude P, Faivre J, Revzani A, Arveux P, Chaplain G, Tretarre B, Launoy G, Lesec'h JM, Raverdy N. Cancer registry data based estimation of regional cancer incidence: application to breast and colorectal cancer in French administrative regions. J Epidemiol Community Health. 1999;53:558-564. [PMID: 10562880 DOI: 10.1136/jech.53.9.558] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
62 Hesch R, Kenemans P. Hormonal prevention of breast cancer: proposal for a change in paradigm. BJOG:An international journal of O&G 1999;106:1006-18. [DOI: 10.1111/j.1471-0528.1999.tb08106.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
63 Paillot B, Czernichow P, Michel P, Merle V, Queuniet AM, Duval C, Daubert H. Incidence of rectosigmoid adenomatous polyps in subjects without prior colorectal adenoma or cancer: a prospective cohort study. Gut 1999;44:372-6. [PMID: 10026323 DOI: 10.1136/gut.44.3.372] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
64 Trebuchet G, Calvé JL, Launois B. Résection cœlioscopique du côlon pour adénocarcinome. Présentation d'une série de 218 cas. Chirurgie 1998;123:343-50. [DOI: 10.1016/s0001-4001(98)80003-2] [Cited by in Crossref: 8] [Article Influence: 0.3] [Reference Citation Analysis]